SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* HUNT M TRUMAN (Last) (First) (Middle) C/O NU SKIN ENTERPRISES, INC. 75 WEST CENTER STREET (Street) PROVO UT 84601 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol NU SKIN ENTERPRISES INC [ NUS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) President & CEO
	3. Date of Earliest Transaction (Month/Day/Year) 12/05/2005
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/05/2005		G	V	7,500	D	(1)	233,362(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)(3)	$20.875							10/20/1998(4)	10/20/2007	Class A Common Stock	19,000		19,000(2)	D
Employee Stock Option (right to buy)(3)	$13.91							08/21/1999(4)	08/21/2008	Class A Common Stock	18,000		18,000(2)	D
Employee Stock Option (right to buy)(3)	$12.94							08/31/2000(4)	08/31/2009	Class A Common Stock	40,000		40,000(2)	D
Employee Stock Option (right to buy)(3)	$6.56							08/31/2001(4)	08/31/2010	Class A Common Stock	35,000		35,000(2)	D
Employee Stock Option (right to buy)(3)	$8.2							02/28/2002(4)	02/28/2011	Class A Common Stock	17,500		17,500(2)	D
Employee Stock Option (right to buy)(3)	$6.85							08/31/2002(4)	08/31/2011	Class A Common Stock	17,500		17,500(2)	D
Employee Stock Option (right to buy)(3)	$8.99							03/01/2003(4)	03/01/2012	Class A Common Stock	17,500		17,500(2)	D
Employee Stock Option (right to buy)(3)	$12							09/03/2003(4)	09/03/2012	Class A Common Stock	17,500		17,500(2)	D
Employee Stock Option (right to buy)(3)	$12.45							01/17/2004(4)	01/17/2013	Class A Common Stock	250,000		250,000(2)	D
Employee Stock Option (right to buy)(3)	$19.15							02/27/2005(4)	02/27/2014	Class A Common Stock	25,000		25,000(2)	D
Employee Stock Option (right to buy)(3)	$26.13							09/01/2005(4)	09/01/2014	Class A Common Stock	25,000		25,000(2)	D
Employee Stock Option (right to buy)(3)	$22.33							02/28/2006(4)	02/28/2015	Class A Common Stock	25,000		25,000(2)	D
Employee Stock Option (right to buy)(3)	$21.34							08/31/2006(4)	08/31/2015	Class A Common Stock	25,000		25,000(2)	D

Explanation of Responses:

1. Price not applicable.

2. Represents number of shares beneficially owned as of December 5, 2005.

3. Previously Reported

4. Becomes exercisable in four equal annual installments beginning on the date indicated.

Remarks:

	Erik Haugen as Attorney-in-Fact for M. Truman Hunt	12/07/2005
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY





The undersigned hereby constitutes and appoints each of Matthew Dorny, Ritch Wood, Mark Adams and Erik Haugen signing singly, the undersigned's

true and lawful attorney-in-fact to:



(1) execute for and on behalf of the undersigned, in the undersigned's

  capacity as (a) an officer and/or director of Nu Skin Enterprises,

 Inc.(the "Company"); or (b) a beneficial owner of the Company's

 common stock, Forms 3, 4, and 5 in accordance with Section 16(a)

 of the Securities Exchange Act of 1934, as amended, and the rules

 thereunder;



(2) do and perform any and all acts for and on behalf of the

 undersigned which may be necessary or desirable to complete

 and execute any such Forms 3, 4, or 5 and timely file such

 forms with the United States Securities and Exchange Commission

 and any stock exchange or similar authority; and



(3) take any other action of any type whatsoever in connection with

 the foregoing which, in the opinion of such attorney-in-fact,

 may be of benefit to, in the best interest of, or legally

 required by, the undersigned, it being understood that the

 documents executed by such attorney-in-fact on behalf of

 the undersigned pursuant to this Power of Attorney shall be

 in such form and shall contain such terms and conditions as

 such attorney-in-fact may approve in such attorney-in-fact's

 discretion.



The undersigned hereby grants to such attorney-in-fact full power and

authority to do and perform any and every act and thing whatsoever

requisite, necessary, or proper to be done in the exercise of any

of the rights and powers herein granted, as fully to all intents

and purposes as the undersigned might or could do if personally

present, with full power of substitution or revocation, hereby ratifying

and confirming all that such attorney-in-fact, or such attorney-in-fact's

substitute or substitutes, shall lawful do or cause to be done

by virtue of this Power of Attorney and the rights and powers herein

granted.  The undersigned acknowledges that the foregoing attorney-in

- -fact, in serving in such capacity at the request of the undersigned,

is not assuming, nor is the Company assuming, any of the undersigned's

responsibilities to comply with Section 16 of the Securities Exchange

Act of 1934, as amended.



This Power of Attorney shall remain in full force and effect until

the undersigned is no longer required to file Forms 3, 4, and 5

with respect to the undersigned's holdings of and transactions

in securities issued by the Company, unless earlier revoked by

the undersigned in a signed writing delivered to the foregoing

attorney-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of the 27th day of September, 2005.





/s/ Truman Hunt